Sridhar Rabindran
About Sridhar Rabindran
Sridhar Rabindran is the Clinical Trial Lead for Oncology Clinical Development at Bristol-Myers Squibb with extensive experience in regulatory filings, team leadership, and scientific publications.
Title and Current Role
Sridhar Rabindran currently serves as the Clinical Trial Lead for Oncology Clinical Development at Bristol-Myers Squibb in Lawrenceville, NJ. In this role, he oversees clinical trials focused on oncology, ensuring all research activities comply with regulatory standards and achieve scientific objectives. His responsibilities include managing cross-functional teams and coordinating clinical trial operations.
Previous Roles and Experience
Before joining Bristol-Myers Squibb, Sridhar Rabindran held several key positions in the pharmaceutical and clinical research industry. From 2010 to 2017, he served as the Director of Medical and Scientific Affairs at Worldwide Clinical Trials, Inc., in King of Prussia, PA. Prior to that, he worked as an Associate Director at GlaxoSmithKline in Collegeville, PA, from 2007 to 2010. His extensive experience also includes a 15-year tenure at Wyeth Research (now Pfizer) as an Associate Director in Pearl River, NY. Early in his career, he spent five years at the National Cancer Institute as an IRTA Fellow/Staff Fellow in Bethesda, MD.
Educational Background
Sridhar Rabindran holds a PhD in Molecular Biology from the University of South Carolina-Columbia. He also earned a B.Sc. in Life Sciences from the University of Bombay. His academic background has provided a solid foundation for his extensive career in clinical research and development, particularly in the field of oncology.
Regulatory and Scientific Expertise
Sridhar Rabindran has extensive experience in regulatory agency filings, including Investigational New Drug (IND) applications and Clinical Trial Applications (CTA). He has led numerous cross-functional and multidisciplinary teams, bringing together experts from various fields to advance clinical research and drug development. Additionally, he has authored multiple clinical and regulatory documents, contributing significantly to the oncology clinical development field.
Presentations and Publications
Throughout his career, Sridhar Rabindran has been active in sharing his knowledge and expertise with the broader scientific community. He has made numerous oral presentations at international scientific meetings and to corporate senior management. His work has been published extensively in premier scientific journals, underscoring his contributions to clinical research and oncology.